{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:23:57Z","timestamp":1794025437035,"version":"4.8.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,11,1]]},"DOI":"10.2169\/internalmedicine.7006-25","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:08:54Z","timestamp":1773698934000},"page":"2901-2904","source":"Crossref","is-referenced-by-count":0,"title":["Decrease in PNH-type Blood Cells after the Cessation of Thrombopoietin Receptor Agonist in a Case of AA-PNH Syndrome"],"prefix":"10.2169","volume":"65","author":[{"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Japan"},{"name":"Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Young NS. Aplastic anemia. N Engl J Med 379: 1643-1656, 2018.","DOI":"10.1056\/NEJMra1413485"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood 124: 2804-2811, 2014.","DOI":"10.1182\/blood-2014-02-522128"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kinoshita T, Inoue N. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol 75: 117-122, 2002.","DOI":"10.1007\/BF02982015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Young NS, Maciejewski JP, Sloand E, et al. The relationship of aplastic anemia and PNH. Int J Hematol 76 (Suppl 2): 168-172, 2002.","DOI":"10.1007\/BF03165111"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jang JH, Tomiyama Y, Miyazaki K, et al. Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II\/III, multicentre, open-label study. Br J Haematol 192: 190-199, 2021.","DOI":"10.1111\/bjh.17190"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Olnes MJ, Scheinberg P, Calvo KR, et al. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 367: 11-19, 2012.","DOI":"10.1056\/NEJMoa1200931"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Townsley DM, Desmond R, Dunbar CE, Young NS. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. Int J Hematol 98: 48-55, 2013.","DOI":"10.1007\/s12185-013-1352-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. Eur J Haematol 87: 37-45, 2011.","DOI":"10.1111\/j.1600-0609.2011.01615.x"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Fattizzo B, Ireland R, Dunlop A, et al. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia. Leukemia 35: 3223-3231, 2021.","DOI":"10.1038\/s41375-021-01190-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Babushok DV. When does a PNH clone have clinical significance? Hematology Am Soc Hematol Educ Program 2021: 143-152, 2021.","DOI":"10.1182\/hematology.2021000245"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A 96: 5209-5214, 1999.","DOI":"10.1073\/pnas.96.9.5209"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Clemente MJ, Przychodzen B, Hirsch CM, et al. Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria. Leukemia 32: 2507-2511, 2018.","DOI":"10.1038\/s41375-018-0138-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tezuka Y, Onoda N, Morishima T, et al. Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag. Int J Hematol 120: 575-586, 2024.","DOI":"10.1007\/s12185-024-03853-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fan X, Desmond R, Winkler T, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Adv 4: 1700-1710, 2020.","DOI":"10.1182\/bloodadvances.2020001657"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Winkler T, Fan X, Cooper J, et al. Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag. Blood 133: 2575-2585, 2019.","DOI":"10.1182\/blood.2019000478"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lee JW, Lee SE, Jung CW, et al. Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial. Lancet Haematol 6: e562-e572, 2019.","DOI":"10.1016\/S2352-3026(19)30153-X"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Desmond R, Townsley DM, Dumitriu B, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood 123: 1818-1825, 2014.","DOI":"10.1182\/blood-2013-10-534743"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lobry C, Bains A, Zamechek LB, Ibrahim S, Aifantis I, Araten DJ. Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH). Exp Hematol Oncol 8: 17, 2019.","DOI":"10.1186\/s40164-019-0142-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yang Y, Cathelin S, Liu ACH, et al. TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling. Nat Commun 16: 2384, 2025.","DOI":"10.1038\/s41467-025-57614-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Korkama ES, Armstrong AE, Jarva H, Meri S. Spontaneous remission in paroxysmal nocturnal hemoglobinuria - return to health or transition into malignancy? Front Immunol 9: 1749, 2018.","DOI":"10.3389\/fimmu.2018.01749"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nassani M, Fakih RE, Passweg J, et al. The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes. Front Oncol 13: 1135160, 2023.","DOI":"10.3389\/fonc.2023.1135160"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_7006-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:33:34Z","timestamp":1794022414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_7006-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":21,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7006-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,1]]},"article-number":"7006-25"}}